John Chalmers AC's Publications
About John Chalmers AC's Publications
Senior Director, Professorial Unit, The George Institute (Australia)- Professor of Medicine, UNSW Sydney
- Emeritus Professor of Medicine at Flinders University and at the University of Sydney
- FAA,
- FAHMS,
- FRACP
-
Nuevas perspectivas en el tratamiento del paciente diabético. Estudio ADVANCE
Hipertensión y Riesgo Vascular Date published: -
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study
European Heart Journal Date published: -
Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial
Expert Review of Endocrinology & Metabolism Date published: -
Proteinuria and Stroke: A Meta-analysis of Cohort Studies
American Journal of Kidney Diseases Date published: -
ADVANCE: Blood Pressure Lowering in Diabetes
The Journal of Clinical Hypertension Date published: -
ADVANCE: Blood Pressure Lowering in Diabetes
The Journal of Clinical Hypertension Date published: -
Risks of cardiovascular disease and severe hypoglycaemia according to cognitive function in people with type 2 diabetes in ADVANCE
Date published: -
ASPIRIN BENEFIT INCREASES WITH DECLINING RENAL FUNCTION AMONG PEOPLE WITH HYPERTENSION
Date published: -
A NEW MODEL FOR PREDICTING THE RISK OF MAJOR CARDIOVASCULAR OUTCOMES IN PEOPLE WITH DIABETES
Date published: -
THE BENEFITS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
Date published: -
RELATIONSHIP BETWEEN AMBULATORY AND CLINIC BLOOD PRESSURE: A HIGH BLOOD PRESSURE RESEARCH COUNCIL OF AUSTRALIA INITIATIVE
Date published: -
THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA
Date published: -
THE EFFECTS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ACCORDING TO BASELINE CARDIOVASCULAR RISK IN THE ADVANCE TRIAL
Date published: -
EFFECTS OF BLOOD PRESSURE LEVELS AT PRESENTATION AND ACHIEVED IN THE FIRST 24 HOURS ON HAEMATOMA GROWTH IN ACUTE INTRACEREBRAL HAEMORRHAGE: THE INTERACT TRIAL
Date published: -
Cardiovascular Risk in Type 2 Diabetes - Reflecting on the ADVANCE Study
European Endocrinology Date published: -
Cardiovascular Risk in Type 2 Diabetes - Reflecting on the ADVANCE Study
US Endocrinology Date published:
